Navigation Links
Mindray Announces FDA 510(k) Clearance of Its A5 Anesthesia System
Date:2/23/2011

MAHWAH, N.J., Feb 23, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its A5 Anesthesia System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The A5 anesthesia device, part of the all new A Series portfolio, is an anesthesia delivery platform that will complement Mindray's broad range of existing ultrasound and patient monitoring systems.

(Photo: http://photos.prnewswire.com/prnh/20110223/CN53658)

The A5's intuitive user interface and ergonomic design simplify workflows. Meanwhile, its 15" touch screen enables clinicians to quickly and easily select ventilation settings, so less time is spent maneuvering and more time is devoted to patient care. The ample work surface, central brake and integrated cable sweeps enhance effectiveness and device mobility.

A5 is the first and only anesthesia machine that conforms to the IHE (Integrating the Healthcare Enterprise) Patient Care Domain (PCD) profile. At no additional charge, every A5 provides data output in the industry standard HL7 protocol. HL7, with the IHE PCD profile, is recognized among anesthesia information management systems (AIMS) and electronic medical records (EMR) systems as the demonstrated industry standard for unambiguous interoperability.

The A5 provides a range of advanced ventilation modes enabling effective care across different patient acuity types. Integrated spirometry offers additional information which enhances careful decision making.

The unique, auxiliary O2/Air Blender reduces the risk of surgical fires by controlling the oxygen concentration under the drape, near the patient's head and chest.

"The A5 Anesthesia System is simple to use and well designed with the most intuitive user interface in the business," said Thomas Barford, Vice President of Anesthesia Systems at Mindray North America. "We are confident that the A5 will be very competitive and well-received in the marketplace."

"The A5 is the first of our new series of anesthesia machines that bring advanced design features to the Mindray portfolio. By creating a highly differentiated product that includes more standard ventilation features, we are significantly expanding our ability to serve the US hospital market," said David Gibson, President, Mindray North America.

About MindrayWe are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.

Press Release A5 510(k) Clearance part number 0002-08-1394For investor and media inquiries, please contact:In the U.S.:   Hoki Luk   Western Bridge, LLC   Tel:   +1-646-808-9150   Email: hoki.luk@westernbridgegroup.comIn China:   Cathy Gao   Mindray Medical International Limited   Tel:   +86-755-2658-2620   Email: cathy.gao@mindray.com
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray Medical to Present at J.P. Morgan China Conference 2010
3. Mindray Medical Provides Mid-Year Update on Product Development
4. Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010
5. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
6. Mindray Launches New Premium M7 Portable Ultrasound System in U.S.
7. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
8. Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference
9. /C O R R E C T I O N - Mindray Medical International Limited /
10. Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer
11. Mindray Medical to Exhibit New Products at 64th China International Medical Equipment Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016 Vestagen Technical Textiles, Inc., a medical ... healthcare and other demanding applications, today announced it has ... replaces Dale Pfost , PhD, who was serving ... also joining Vestagen,s Board of Directors. ® ... barrier technologies that combines fluid repellent, antimicrobial and breathability ...
(Date:2/8/2016)... Ill. , Feb. 8, 2016  Astellas Pharma Inc. ... announced the promotion of James Robinson as president, ... company,s operations in North and South America ... Astellas Pharma US, representing the commercial organization in ... in 2013. Masao Yoshida , who is ...
(Date:2/8/2016)... , Feb. 8, 2016  CTI BioPharma Corp. ... Company received written communication from the U.S. Food and ... FDA has placed a partial clinical hold on the ... Drug ("IND") application for pacritinib. This clinical hold impacts ... the IND and will also affect planned clinical trials. ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... , ... According to research by the National Association of ... be certified or obtain continuing education. To increase patient awareness of the lack ... campaign to inform dentists and patients about the possible lack of skills and ...
(Date:2/7/2016)... Texas (PRWEB) , ... February 07, 2016 , ... ... new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and information ... MyDecision™ combines three elements to cut the cost of providing employee healthcare benefits ...
(Date:2/6/2016)... San Rafael, CA (PRWEB) , ... February 06, 2016 , ... ... 2016 Youth Ultimate Coaching Conference (YUCC) . This event brings together top non-profit leaders, ... is “Gender Equity and Girls Ultimate”. Valerio Iani, Bay Area Disc Program Director of ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... disorder treatment helps to reduce the frequency and level of relapse. ... Re-Establishing Healthy Identity and Purpose,” will explore the critical tasks of the recovery ...
(Date:2/5/2016)... Ontario (PRWEB) , ... February 05, 2016 , ... ... announced the availability of the company's lighter, sleeker next generation LYNX VR Indoor ... plant. , Improvements in design and manufacturing not only reduce the weight ...
Breaking Medicine News(10 mins):